Oxford Endovascular
Signal active
Organization
Contact Information
Overview
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
About
Industries
Biotechnology, Health Care, Medical
Founded
2015
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Oxford Endovascular headquartered in Europe, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $3.1B in funding across 108 round(s). With a team of 1-10 employees, Oxford Endovascular is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Oxford Endovascular, raised $3.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
9
Investors
1
Lead Investors
0
Total Funding Amount
$28.4M
Details
3
Oxford Endovascular has raised a total of $28.4M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 9.9M | ||
| 2024 | Early Stage Venture | 10.2M | ||
| 2015 | Seed | 3.0M |
Investors
Oxford Endovascular is funded by 32 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Oxford Endovascular | - | FUNDING ROUND - Oxford Endovascular | 10.2M |
| Vulpes Investment Management Pte Ltd | - | FUNDING ROUND - Vulpes Investment Management Pte Ltd | 10.2M |
| Oxford Endovascular | - | FUNDING ROUND - Oxford Endovascular | 3.0M |
| Parkwalk Advisors | - | FUNDING ROUND - Parkwalk Advisors | 3.0M |
Recent Activity
There is no recent news or activity for this profile.